QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)

Cosmos Health (COSM) Competitors

$0.78
+0.02 (+2.64%)
(As of 02/28/2024 ET)

COSM vs. MEDS, BIMI, AIH, IKT, BIAF, POAI, ONTX, INDP, NRSN, and COCP

Should you be buying Cosmos Health stock or one of its competitors? The main competitors of Cosmos Health include TRxADE HEALTH (MEDS), BIMI (BIMI), Aesthetic Medical International Holdings Group (AIH), Inhibikase Therapeutics (IKT), bioAffinity Technologies (BIAF), Predictive Oncology (POAI), Onconova Therapeutics (ONTX), Indaptus Therapeutics (INDP), NeuroSense Therapeutics (NRSN), and Cocrystal Pharma (COCP). These companies are all part of the "medical" sector.

Cosmos Health vs.

TRxADE HEALTH (NASDAQ:MEDS) and Cosmos Health (NASDAQ:COSM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

TRxADE HEALTH presently has a consensus target price of $26.25, indicating a potential upside of 208.82%. Given Cosmos Health's higher probable upside, equities research analysts clearly believe TRxADE HEALTH is more favorable than Cosmos Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TRxADE HEALTH
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cosmos Health
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

TRxADE HEALTH has higher earnings, but lower revenue than Cosmos Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TRxADE HEALTH$11.45M0.90-$3.47M-$6.94-1.22
Cosmos Health$50.35M0.26-$13.83MN/AN/A

TRxADE HEALTH has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 6.45, meaning that its share price is 545% more volatile than the S&P 500.

In the previous week, Cosmos Health had 16 more articles in the media than TRxADE HEALTH. MarketBeat recorded 17 mentions for Cosmos Health and 1 mentions for TRxADE HEALTH. Cosmos Health's average media sentiment score of 1.04 beat TRxADE HEALTH's score of 0.48 indicating that TRxADE HEALTH is being referred to more favorably in the media.

Company Overall Sentiment
TRxADE HEALTH Positive
Cosmos Health Neutral

4.1% of TRxADE HEALTH shares are held by institutional investors. Comparatively, 4.3% of Cosmos Health shares are held by institutional investors. 48.4% of TRxADE HEALTH shares are held by company insiders. Comparatively, 18.7% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cosmos Health received 20 more outperform votes than TRxADE HEALTH when rated by MarketBeat users. Likewise, 70.69% of users gave Cosmos Health an outperform vote while only 52.50% of users gave TRxADE HEALTH an outperform vote.

CompanyUnderperformOutperform
TRxADE HEALTHOutperform Votes
21
52.50%
Underperform Votes
19
47.50%
Cosmos HealthOutperform Votes
41
70.69%
Underperform Votes
17
29.31%

Cosmos Health has a net margin of -31.48% compared to Cosmos Health's net margin of -78.18%. TRxADE HEALTH's return on equity of -28.54% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
TRxADE HEALTH-78.18% -69.22% -23.52%
Cosmos Health -31.48%-28.54%-17.69%

Summary

Cosmos Health beats TRxADE HEALTH on 9 of the 14 factors compared between the two stocks.


Get Cosmos Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for COSM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COSM vs. The Competition

MetricCosmos HealthDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$13.17M$17.51B$4.98B$7.46B
Dividend YieldN/A1.22%2.90%3.88%
P/E RatioN/A21.83260.3018.41
Price / Sales0.262.563,085.5364.70
Price / CashN/A11.0895.4054.69
Price / Book0.2110.274.464.67
Net Income-$13.83M$721.61M$113.20M$210.96M
7 Day Performance-3.62%2.03%5.08%2.50%
1 Month Performance-25.92%5.69%13.05%4.82%
1 Year Performance-76.85%30.00%11.95%7.46%

Cosmos Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MEDS
TRxADE HEALTH
2.9827 of 5 stars
$9.09
+98.0%
$26.25
+188.8%
+50.9%$11.00M$11.45M-1.3133Positive News
Gap Up
High Trading Volume
BIMI
BIMI
0 of 5 stars
$3.33
+9.2%
N/A+214.2%$38.59M$11.83M0.00296Short Interest ↓
Gap Up
AIH
Aesthetic Medical International Holdings Group
0 of 5 stars
$0.45
-2.2%
N/A-58.7%$14.08M$97.15M0.001,167Short Interest ↓
Positive News
Gap Down
High Trading Volume
IKT
Inhibikase Therapeutics
2.7588 of 5 stars
$2.28
-3.4%
$27.00
+1,084.2%
-46.9%$14.07M$120,000.00-0.586News Coverage
Positive News
BIAF
bioAffinity Technologies
0 of 5 stars
$1.50
-1.3%
N/A+24.8%$14.25M$321,489.000.0014Short Interest ↑
POAI
Predictive Oncology
0 of 5 stars
$3.43
+5.5%
N/A-63.4%$13.93M$1.51M-0.7431
ONTX
Onconova Therapeutics
3.3632 of 5 stars
$0.68
+1.5%
$11.00
+1,515.3%
+0.0%$14.30M$230,000.00-0.7016Analyst Report
Short Interest ↓
News Coverage
Gap Up
INDP
Indaptus Therapeutics
3.1264 of 5 stars
$1.72
+5.5%
$12.00
+597.7%
+15.5%$14.45MN/A-0.956Short Interest ↑
NRSN
NeuroSense Therapeutics
0 of 5 stars
$1.33
-2.9%
N/A-6.2%$14.55MN/A-1.4114Positive News
COCP
Cocrystal Pharma
2.5321 of 5 stars
$1.44
-8.3%
$10.00
+594.4%
-24.9%$14.65MN/A-0.6912Short Interest ↑
Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:COSM) was last updated on 2/28/2024 by MarketBeat.com Staff